Financial Data and Key Metrics Changes - Fourth quarter revenues reached $31.5 million, a 41% year-over-year increase, marking the highest quarterly result in the company's history [5][17] - Positive operating cash flow was achieved for the first time, driven by upfront payments from the Midjourney deal [5] - Adjusted EBITDA loss improved to $3.2 million in Q4 2025 from a loss of $9.1 million in Q4 2024, reflecting a 65% improvement [23] - Full year 2025 total revenue increased by 19% to $97.6 million compared to 2024 [21] Business Line Data and Key Metrics Changes - Core POCUS revenue grew 15% year-over-year, following a record 35% growth in the previous year [9] - Butterfly Embedded revenue significantly contributed to the overall growth, particularly from the Midjourney partnership [18][21] - Product revenue was $18.1 million, a 23% increase year-over-year, while software and other services revenue was $13.4 million, up 76% year-over-year [20][21] Market Data and Key Metrics Changes - U.S. revenue was $26.8 million, a 55% increase year-over-year, driven by strong demand in the core business and Butterfly Embedded [19] - International revenue decreased by 6% year-over-year to $4.7 million, with iQ3 sales up 42% but iQ+ sales down 79% [19] Company Strategy and Development Direction - The company aims to strengthen its core franchise and expand its semiconductor ultrasound platform beyond handheld devices [5][8] - The strategic growth plan includes three core tenets: accelerating the core POCUS business, executing strategic initiatives for new care settings, and delivering an R&D roadmap for next-generation chips [8][12] - The Midjourney partnership is seen as a foundational step towards transforming Butterfly into a platform company [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in macro trends and deal cycles, expecting to carry momentum into 2026 [9] - The company anticipates nominal revenue from home care in 2026, with significant growth potential starting in 2027 [49][52] - The overall outlook for 2026 is positive, with expected revenue growth of 20% to 24% [27][28] Other Important Information - The company achieved a cash and cash equivalent balance of $154.5 million at year-end, with a cash use improvement of $26.4 million compared to 2024 [24] - The company is focused on expanding its home care business and enhancing its AI capabilities through the Compass AI initiative [25][30] Q&A Session Summary Question: Can you provide details on the timing of the technology offering from Midjourney? - Management indicated that something is expected from Midjourney in the near term, emphasizing their role as enablers for partners [38][39] Question: What is the revenue opportunity for the home care franchise? - Management believes the home care business could represent a $40 million-$50 million revenue opportunity if successful [50][51] Question: How is the macro environment affecting the company? - Management noted improved confidence in the macro environment, with some downward pressure from tariffs but overall positive trends [56][57] Question: What is the outlook for partnerships with medical schools? - Management expects strong contributions from medical schools in 2026, as students increasingly seek ultrasound training [59][61]
Butterfly Network(BFLY) - 2025 Q4 - Earnings Call Transcript